Carey Pilato is a communications consultant in the pharmaceuticals, and life science industry, with significant experience in agency and corporate settings. Carey has diverse professional communications experience having worked for three members of Congress and Fleishman Hillard, Edelman, Ogilvy, Cooney Waters, Pfizer, and Sanofi. He earned a Master of Science degree in strategic communications from Purdue University. He is passionate about advances in pharma, biotech, medical devices, health technology, and public health.
Some of his notable career achievements include directing global and U.S. product communications, issues management, co-promotion agreements, and scientific & medical developments for (four) blockbuster products including DARZALEX ($4 billion in sales); IMBRUVICA ($8 billion in sales); Prevnar 13 ($6 billion in sales); and Lipitor ($4 Billion in sales, and launching the Biosimilars Forum, an advocacy group for a new class of biologic therapies.